Neuroinflammation in Adaptive Immunodeficient Mice with Colitis-like Symptoms

Area of Science:

• Neuroimmunology
• Gastroenterology
• Gut-Brain Axis Research

Background:

• Systemic inflammation is increasingly linked to neurological disorders.
• A bidirectional relationship exists between inflammatory bowel diseases (IBD) and neurological conditions via the gut-brain axis.
• The specific role of adaptive immune cells in IBD-induced neuroinflammation is not fully understood.

Purpose of the Study:

• To investigate the role of adaptive immune cells in IBD-induced neuroinflammation using a severe combined immune-deficient (SCID) mouse model.
• To analyze the temporal dynamics of neuroinflammation in response to dextran sulfate sodium (DSS)-induced colitis.

Main Methods:

• Induction of colitis in SCID mice using 1%, 3%, or 5% DSS for 5 days.
• Monitoring of clinical parameters: body weight, colon length, disease activity index (DAI), and colonic crypt damage.
• Analysis of colonic and brain inflammatory cytokines, microglial morphology, and neuronal counts.

Main Results:

• Colitis symptoms, including reduced colon length and crypt damage, were observed in the 3% DSS group by day 7.
• While colonic inflammation peaked early, significant neuroinflammation and microglial activation were not detected in the brain at this stage.
• Delayed neuroinflammation was evident by day 21, even in the absence of adaptive immune cells.

Conclusions:

• Adaptive immune cells are not essential for the development of delayed neuroinflammation in this IBD model.
• The study provides a novel animal model to explore the fundamental immune mechanisms of the gut-brain axis in IBD-related neuroinflammation.
• Findings may inform the development of immune cell-based therapies for IBD-associated neurological complications.